Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

被引：0
|
作者：
Kristof Cuppens
Liesbet Lodewyckx
Ingel Demedts
Lore Decoster
Benoît Colinet
Koen Deschepper
Annelies Janssens
Daniella Galdermans
Thierry Pieters
机构：
[1] Jessa Hospital,Department of Pulmonology and Thoracic Oncology
[2] AstraZeneca Belgium & Luxemburg,Department of Pulmonary Diseases
[3] AZ Delta,Department of Medical Oncology
[4] Oncologisch Centrum,Department of Pneumology and Thoracic Oncology, Grand Hôpital de Charleroi
[5] Vrije Universiteit Brussel,Department of Pulmonology and Thoracic Oncology
[6] Notre Dame,Department of Pulmonology, Cliniques Universitaires Saint
[7] AZ Nikolaas,Luc
[8] Antwerp University Hospital,undefined
[9] ZNA Middelheim,undefined
[10] Université Catholique de Louvain,undefined
来源：
Drugs - Real World Outcomes | 2021年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 152
页数：11
相关论文
共 50 条
  • [1] Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study
    Cuppens, Kristof
    Lodewyckx, Liesbet
    Demedts, Ingel
    Decoster, Lore
    Colinet, Benoit
    Deschepper, Koen
    Janssens, Annelies
    Galdermans, Daniella
    Pieters, Thierry
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 141 - 152
  • [2] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Cliff Molife
    Katherine B. Winfree
    Hollie Bailey
    Yulia D’yachkova
    Cameron Forshaw
    Sangmi Kim
    Kaisa-Leena Taipale
    Tarun Puri
    Advances in Therapy, 2023, 40 : 3135 - 3168
  • [3] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Molife, Cliff
    Winfree, Katherine B.
    Bailey, Hollie
    D'yachkova, Yulia
    Forshaw, Cameron
    Kim, Sangmi
    Taipale, Kaisa-Leena
    Puri, Tarun
    ADVANCES IN THERAPY, 2023, 40 (07) : 3135 - 3168
  • [4] Furmonertinib treatment in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, H.
    Wang, L.
    Wu, Y.
    Wu, Y.
    Ma, S.
    Sen, Y.
    Zhen, H.
    Mo, Y.
    Zhang, C.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S1697 - S1697
  • [5] Real-world treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer: Results from a large retrospective study (REFLECT)
    Pluzanski, A.
    Donev, I. Shterev
    Gafton, B.
    Janzic, U.
    Vidovic, D.
    Lupu, R.
    Teodorescu, G.
    Ciuleanu, T-E.
    ANNALS OF ONCOLOGY, 2021, 32 : S973 - S974
  • [6] Real-world outcomes of anti-EGFR therapy in advanced non-small cell lung cancer EGFR mutated in Peru
    Galvez-Nino, Marco
    Ruiz, Rossana
    Roque, Katia
    Coanqui, Ofelia
    Valdivieso, Natalia
    Olivera, Mivael
    Ganti, Apar Kishor
    Mas, Luis
    THORACIC CANCER, 2023, 14 (01) : 61 - 67
  • [7] Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT)
    Janzic, Urska
    Turnsek, Nina
    Dediu, Mircea
    Donev, Ivan Shterev
    Lupu, Roxana
    Teodorescu, Gabriela
    Ciuleanu, Tudor E.
    Pluzanski, Adam
    CURRENT ONCOLOGY, 2022, 29 (08) : 5833 - 5845
  • [8] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
  • [9] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [10] A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer
    Huang, Chun-Yao
    Huang, Hui-Li
    Lan, Chou-Chin
    Huang, Yi-Chih
    Wu, Yao-Kuang
    BMC CANCER, 2023, 23 (01)
12345